Ioannis Pappas is currently Professor of Pharmacology and Toxicology in the Faculty of Veterinary Medicine of the University of Thessaly, Greece. His research topics mainly include PTD-IVT-mRNA transfer and cancer immunotherapy; the design and development of new anticancer agents; the study of antibiotic resistance; neurodegenerative diseases and potent targets; and the evaluation of the potency and safety of drugs and vaccines. Part of his work is on the proliferation, differentiation, and apoptosis of cancer cells. He has also developed a number of chemical compounds that inhibit the c-myc oncogene, induce Nrf-2, etc. He has recently focused on mRNA transfer for the therapy of metabolic/genetic disorders and on CAR immunotherapy of cancer. He has published more than 45 original articles in reputable international journals and 80 articles at scientific conferences. He has participated in 20 research projects. He published two main reviews entitled “Mechanisms involved in the induced differentiation of leukemic cells” and “In Vitro-Transcribed mRNAs as a new generation of therapeutics at the dawn of the 21st century: Exploitation of peptides as carriers for their intracellular delivery”. He is a co-inventor of a patent concerning the deliverable PTD-IVT-mRNAs (WO2021/094792 A1/ 20.05.2021). He has long experience in tissue culture, molecular biology, biochemistry, and chemistry techniques.